KR100695920B1 - 개질 포르피란 - Google Patents
개질 포르피란 Download PDFInfo
- Publication number
- KR100695920B1 KR100695920B1 KR1020050002643A KR20050002643A KR100695920B1 KR 100695920 B1 KR100695920 B1 KR 100695920B1 KR 1020050002643 A KR1020050002643 A KR 1020050002643A KR 20050002643 A KR20050002643 A KR 20050002643A KR 100695920 B1 KR100695920 B1 KR 100695920B1
- Authority
- KR
- South Korea
- Prior art keywords
- salt
- porpyran
- porphyran
- modified
- sulfate
- Prior art date
Links
- 229920001715 Porphyran Polymers 0.000 title claims abstract description 92
- 150000003839 salts Chemical class 0.000 claims abstract description 85
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical group S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 38
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims abstract description 27
- 238000004519 manufacturing process Methods 0.000 claims abstract description 18
- 235000013305 food Nutrition 0.000 claims abstract description 15
- 239000002537 cosmetic Substances 0.000 claims abstract description 14
- 238000005342 ion exchange Methods 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 49
- 230000008569 process Effects 0.000 claims description 30
- 239000000463 material Substances 0.000 claims description 8
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims description 8
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical class NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 6
- 239000003729 cation exchange resin Substances 0.000 claims description 6
- 159000000000 sodium salts Chemical group 0.000 claims description 6
- 238000001179 sorption measurement Methods 0.000 claims description 6
- 239000003599 detergent Substances 0.000 claims description 5
- 159000000007 calcium salts Chemical class 0.000 claims description 4
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical group [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 1
- 229940023913 cation exchange resins Drugs 0.000 claims 1
- 125000000487 histidyl group Chemical class [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 claims 1
- 229910052938 sodium sulfate Inorganic materials 0.000 claims 1
- 235000011152 sodium sulphate Nutrition 0.000 claims 1
- 230000000704 physical effect Effects 0.000 abstract description 24
- 108010003272 Hyaluronate lyase Proteins 0.000 abstract description 22
- 102000001974 Hyaluronidases Human genes 0.000 abstract description 22
- 229960002773 hyaluronidase Drugs 0.000 abstract description 22
- 230000001766 physiological effect Effects 0.000 abstract description 21
- 230000002401 inhibitory effect Effects 0.000 abstract description 16
- 241001474374 Blennius Species 0.000 abstract description 15
- 239000000243 solution Substances 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 210000003491 skin Anatomy 0.000 description 17
- 230000000694 effects Effects 0.000 description 15
- 244000236655 Diospyros kaki Species 0.000 description 13
- 239000000284 extract Substances 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 229920001282 polysaccharide Polymers 0.000 description 12
- 239000005017 polysaccharide Substances 0.000 description 12
- 235000011511 Diospyros Nutrition 0.000 description 11
- 150000004676 glycans Chemical class 0.000 description 11
- 238000009472 formulation Methods 0.000 description 10
- -1 sulfate polysaccharides Chemical class 0.000 description 10
- 241000195493 Cryptophyta Species 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 9
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 239000000344 soap Substances 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 238000005341 cation exchange Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000007803 itching Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 241000206613 Pyropia yezoensis Species 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 150000001483 arginine derivatives Chemical class 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 229920002674 hyaluronan Polymers 0.000 description 5
- 229960003160 hyaluronic acid Drugs 0.000 description 5
- 210000002540 macrophage Anatomy 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 235000003434 Sesamum indicum Nutrition 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241001512722 Ecklonia cava Species 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 241000206607 Porphyra umbilicalis Species 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 241000207961 Sesamum Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 150000002411 histidines Chemical class 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 229940122393 Hyaluronidase inhibitor Drugs 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000005909 Kieselgur Substances 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 241000206608 Pyropia tenera Species 0.000 description 2
- 241000206572 Rhodophyta Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 201000008937 atopic dermatitis Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000005562 fading Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 239000003022 immunostimulating agent Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 235000014214 soft drink Nutrition 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- WZYRMLAWNVOIEX-MOJAZDJTSA-N (2s)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyacetaldehyde Chemical compound O=C[C@@H](O)[C@@H]1OC[C@H](O)[C@H]1O WZYRMLAWNVOIEX-MOJAZDJTSA-N 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- ZDSCFBCGDDCJFZ-UHFFFAOYSA-N 2-(methylamino)ethanesulfonic acid;sodium Chemical compound [Na].CNCCS(O)(=O)=O ZDSCFBCGDDCJFZ-UHFFFAOYSA-N 0.000 description 1
- MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 description 1
- WXWQJUNPKFWAEX-UHFFFAOYSA-N 2h-pyran-2-carbaldehyde Chemical class O=CC1OC=CC=C1 WXWQJUNPKFWAEX-UHFFFAOYSA-N 0.000 description 1
- DCQFFOLNJVGHLW-UHFFFAOYSA-N 4'-Me ether-Punctatin+ Natural products O1C(O)C(O)C2OCC1C2O DCQFFOLNJVGHLW-UHFFFAOYSA-N 0.000 description 1
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 101710128038 Hyaluronan synthase Proteins 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- GFHNQKKLOLZRQE-UHFFFAOYSA-N O6-methyl-D-galactose Natural products COCC(O)C(O)C(O)C(O)C=O GFHNQKKLOLZRQE-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical group [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- WZYRMLAWNVOIEX-UHFFFAOYSA-N cinnamtannin B-2 Natural products O=CC(O)C1OCC(O)C1O WZYRMLAWNVOIEX-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008341 cosmetic lotion Substances 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 238000000909 electrodialysis Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 229960000587 glutaral Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- WUUHFRRPHJEEKV-UHFFFAOYSA-N tripotassium borate Chemical compound [K+].[K+].[K+].[O-]B([O-])[O-] WUUHFRRPHJEEKV-UHFFFAOYSA-N 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
- B32B5/02—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by structural features of a fibrous or filamentary layer
- B32B5/12—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by structural features of a fibrous or filamentary layer characterised by the relative arrangement of fibres or filaments of different layers, e.g. the fibres or filaments being parallel or perpendicular to each other
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B31—MAKING ARTICLES OF PAPER, CARDBOARD OR MATERIAL WORKED IN A MANNER ANALOGOUS TO PAPER; WORKING PAPER, CARDBOARD OR MATERIAL WORKED IN A MANNER ANALOGOUS TO PAPER
- B31B—MAKING CONTAINERS OF PAPER, CARDBOARD OR MATERIAL WORKED IN A MANNER ANALOGOUS TO PAPER
- B31B50/00—Making rigid or semi-rigid containers, e.g. boxes or cartons
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
- F16L11/00—Hoses, i.e. flexible pipes
- F16L11/02—Hoses, i.e. flexible pipes made of fibres or threads, e.g. of textile which may or may not be impregnated, or provided with an impermeable layer, e.g. fire-hoses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Birds (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Sustainable Development (AREA)
- Pulmonology (AREA)
- Textile Engineering (AREA)
- Diabetes (AREA)
- Mechanical Engineering (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
공 정 | |
공정 예 1 공정 예 2 공정 예 3 공정 예 4 공정 예 5 공정 예 6 공정 예 7 공정 예 8 공정 예 9 | 처리하지 않음 에탄올첨가에 의해 침전한 포르피란을 증류수로 재용해시킴 양이온교환공정만, 중화하지 않음 양이온교환후, NaOH로 중화 양이온교환후, KOH로 중화 양이온교환후, Ca(OH)2로 중화 양이온교환후, 아르기닌으로 중화 양이온교환후, 오르니틴으로 중화 양이온교환후, 히스티딘으로 중화 |
히알루로니다제저해활성IC50(mg/ml) | |
공정예 1 | 0.520 |
공정예 2 | 0.610 |
공정예 3 | 0.200 |
공정예 4 | 0.030 |
공정예 5 | 0.020 |
공정예 6 | 0.010 |
공정예 7 | 0.040 |
공정예 8 | 0.070 |
공정예 9 | 0.060 |
성분 | 배 합 량(중량%) | ||
처방예1 | 처방예2 | 처방예3 | |
실시예2의 포르피란 용액 실시예1-공정예2의 포르피란용액 라우르산 미리스틴 96%수산화 칼륨 야쟈유지방산 메틸타우린나트륨 야쟈유지방산 아미드프로필 베타인 야쟈유지방산 디에탄올 아미드 에데트산 나트륨 파라옥시 안식향산 메틸 식염 증류수 | 0 0 2.3 3.2 1.5 2.9 7.2 3 0.2 0.2 1 78.5 | 2 0 2.3 3.2 1.5 2.9 7.2 3 0.2 0.2 1 76.5 | 0 2 2.3 3.2 1.5 2.9 7,2 3 0.2 0.2 1 76.5 |
계 | 100 | 100 | 100 |
살결의 촉촉함 | 가려움의 정도 | |
처 방 예1 처 방 예2 처 방 예3 | 2.8 4.2 3.4 | 2.8 4.4 3.6 |
성 분 | 배 합 량(중량%) | ||
처방예1 | 처방예2 | 처방예3 | |
그리세린 1,3-브틸렌글리코올 실시예2에서 조제한 포르피란 실시예1-공정예2의 포르피란 에탄올 PEG6000 폴리옥시 에틸렌메틸 글루코시드 파라옥시 안식향산 에스텔 폴리옥시 에틸렌 경화피마자유 정제수 | 6.00 2.00 5.00 0.00 6.00 0.50 0.50 0.15 0.10 79.75 | 6.00 2.00 0.00 5.00 6.00 0.50 0.50 0.15 0.10 79.75 | 6.00 2.00 0.00 0.00 6.00 0.50 0.50 0.15 0.10 84.75 |
계 | 100.00 | 100.00 | 100.00 |
살결의촉촉함 | 살결의매끈함 | 살결의끈적임 | |
처방예 1 처방예 3 | 4.2 1.9 | 4.4 2.8 | 3.9 3.7 |
Claims (17)
- 포르피란 중의 황산기로부터 염을 분리시켜 염을 제거하는 공정을 포함하는 것을 특징으로 하는 개질된 포르피란의 제조방법.
- 포르피란 중의 황산기로부터 염을 분리하여 제거한 후, 그 황산기를 분리된 염과는 다른 염류를 사용하여 그 염류의 황산염으로 하는 공정을 포함하는 것을 특징으로 하는 개질된 포르피란의 제조방법
- 포르피란 중의 황산기의 염을 이온교환에 의하여 변환시켜, 변환된 염류의 황산염으로 하는 공정을 포함하는 것을 특징으로 하는 개질된 포르피란의 제조방법.
- 제1항 내지 제3항에서 선택된 어느 한 항에 있어서, 포르피란 중의 황산기의 염의 분리 및 염의 제거, 또는 포르피란 중의 황산기의 염의 이온교환에 의한 변환을, 양이온교환수지를 사용하여 실시하는 것을 특징으로 하는 개질된 포르피란의 제조방법.
- 제2항 또는 제3항에 있어서, 상기 염류의 황산염이, 황산나트륨염, 칼륨염, 칼슘염, 아르기닌염, 오르니틴염, 또는 히스티딘염인 것을 특징으로 하는 개질된 포르피란의 제조방법.
- 상기 제1항에 기재한 제조방법에 의해 제조되며, 포르피란 중의 황산기의 염이 분리하여 유리의 황산기로 되어있는 것을 특징으로 하는 개질된 포르피란.
- 제2항 또는 제3항에 기재된 제조방법에 의해 제조되며, 포르피란 중의 황산기의 염이 분리된 염과는 다른 염류로 변환되어 있는 것을 특징으로 하는 개질된 포르피란.
- 제7항에 있어서, 상기 변환된 염류가 나트륨염이며, 용액으로 하였을 경우에 높은 안정성을 나타내며, 피부에 대한 흡착성이 증강되어 있는 것을 특징으로 하는 개질된 포르피란.
- 제7항에 있어서, 상기 변환된 염류가 아르기닌염이며, 용액으로 하였을 경우에 높은 안정성을 나타내며, 피부에 대한 흡착성이 증강되어 있는 것을 특징으로 하는 개질된 포르피란.
- 삭제
- 삭제
- 제6항에 기재된 개질된 포르피란을 첨가한 것을 특징으로 하는 화장재료.
- 제7항에 기재된 개질된 포르피란을 첨가한 것을 특징으로 하는 화장재료.
- 제6항에 기재된 개질된 포르피란을 첨가한 것을 특징으로 하는 세제.
- 제7항에 기재된 개질된 포르피란을 첨가한 것을 특징으로 하는 세제.
- 제6항에 기재된 개질된 포르피란을 첨가한 것을 특징으로 하는 음식물.
- 제7항에 기재된 개질된 포르피란을 첨가한 것을 특징으로 하는 음식물.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2004-00072426 | 2004-03-15 | ||
JP2004072426A JP5004409B2 (ja) | 2004-03-15 | 2004-03-15 | 改質ポルフィラン |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050092342A KR20050092342A (ko) | 2005-09-21 |
KR100695920B1 true KR100695920B1 (ko) | 2007-03-20 |
Family
ID=34918612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050002643A KR100695920B1 (ko) | 2004-03-15 | 2005-01-11 | 개질 포르피란 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20050201962A1 (ko) |
JP (1) | JP5004409B2 (ko) |
KR (1) | KR100695920B1 (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4979978B2 (ja) * | 2006-05-02 | 2012-07-18 | 株式会社白子 | 新規可食性水溶性フィルム |
WO2008066193A1 (fr) * | 2006-11-27 | 2008-06-05 | Chisso Corporation | Composition cosmétique |
JP2008255066A (ja) * | 2007-04-06 | 2008-10-23 | Shirako:Kk | 新規パック用化粧品組成物 |
CN103864946A (zh) * | 2014-03-03 | 2014-06-18 | 张忠山 | 一种坛紫菜多糖定位硫酸酯化方法 |
CN109549951A (zh) * | 2019-01-25 | 2019-04-02 | 大连海洋大学 | 笼目海带褐藻聚糖硫酸酯复方免疫增强剂 |
WO2024054688A2 (en) * | 2022-09-10 | 2024-03-14 | Native Code Bio, Llc | Therapeutic combinations for movement disorders |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6460002A (en) * | 1987-08-31 | 1989-03-07 | Nec Corp | Polarized wave converter |
JPS6460003A (en) * | 1987-08-31 | 1989-03-07 | Nec Corp | Waveguide low-pass filter |
JPH08841A (ja) * | 1994-06-22 | 1996-01-09 | Oriental Sangyo Kk | 綱渡り用バランス維持具及びこれを備えた車両 |
JPH11310603A (ja) * | 1998-04-28 | 1999-11-09 | Yamamoto Noriten:Kk | ポルフィランの精製方法及びポルフィラン精製物 |
JP2004027192A (ja) * | 2002-03-14 | 2004-01-29 | Sagaken Chiiki Sangyo Shien Center | ポルフィランの製造方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA980261A (en) * | 1972-08-16 | 1975-12-23 | Uniroyal Ltd. | Process for the purification and concentration of solutions derived from marine algae |
JPS62428A (ja) * | 1985-06-25 | 1987-01-06 | Shiraha Akira | 肥満抑制剤 |
JPH08841B2 (ja) * | 1990-12-27 | 1996-01-10 | 株式会社紀文食品 | ポルフィランの製造法 |
JPH1060003A (ja) * | 1996-08-13 | 1998-03-03 | Chikanosuke Oki | ポルフィランを製造する方法 |
JP4001443B2 (ja) * | 1999-06-24 | 2007-10-31 | 日清紡績株式会社 | リン吸収阻害剤及びそれを含む治療剤 |
US6248360B1 (en) * | 2000-06-21 | 2001-06-19 | International Health Management Associates, Inc. | Complexes to improve oral absorption of poorly absorbable antibiotics |
-
2004
- 2004-03-15 JP JP2004072426A patent/JP5004409B2/ja not_active Expired - Fee Related
-
2005
- 2005-01-11 KR KR1020050002643A patent/KR100695920B1/ko not_active IP Right Cessation
- 2005-03-14 US US11/078,617 patent/US20050201962A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6460002A (en) * | 1987-08-31 | 1989-03-07 | Nec Corp | Polarized wave converter |
JPS6460003A (en) * | 1987-08-31 | 1989-03-07 | Nec Corp | Waveguide low-pass filter |
JPH08841A (ja) * | 1994-06-22 | 1996-01-09 | Oriental Sangyo Kk | 綱渡り用バランス維持具及びこれを備えた車両 |
JPH11310603A (ja) * | 1998-04-28 | 1999-11-09 | Yamamoto Noriten:Kk | ポルフィランの精製方法及びポルフィラン精製物 |
JP2004027192A (ja) * | 2002-03-14 | 2004-01-29 | Sagaken Chiiki Sangyo Shien Center | ポルフィランの製造方法 |
Also Published As
Publication number | Publication date |
---|---|
US20050201962A1 (en) | 2005-09-15 |
JP2005255932A (ja) | 2005-09-22 |
KR20050092342A (ko) | 2005-09-21 |
JP5004409B2 (ja) | 2012-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cheok et al. | Current trends of tropical fruit waste utilization | |
KR100695920B1 (ko) | 개질 포르피란 | |
KR100594342B1 (ko) | 화장료 | |
WO2008018448A1 (fr) | Activateur comprenant un bio-tensioactif comme ingrédient actif, un mannosyl érythritol lipide et son procédé de préparation | |
Sudha et al. | Industrial applications of marine carbohydrates | |
KR20190079514A (ko) | 알로에 발효물을 유효성분으로 함유하는 피부 보습용 화장료 조성물 | |
Singh et al. | A review on the valorization of coconut shell waste | |
KR101777799B1 (ko) | 국화 숙성물 함유 화장료 조성물 | |
CN107744081A (zh) | 一种胡杨碱苏打水 | |
KR101989654B1 (ko) | 레몬머틀 추출물을 포함하는 음료 조성물 | |
KR101841099B1 (ko) | 저분자 후코이단이 함유된 마스크팩 화장료 조성물 및 그 제조방법 | |
KR101421537B1 (ko) | 다시마 아임계수 추출물을 유효성분으로 포함하는 화장료 조성물 | |
KR102655418B1 (ko) | 녹용 유래 저분자 콜라겐의 제조 방법 | |
KR100987518B1 (ko) | 엽산이 혼입된 대두 발효 고분자물질 및 이를 포함하는 조성물 | |
JP2024500509A (ja) | 新規なサッカロミセス・セレビシエ菌株及びその用途 | |
KR102137752B1 (ko) | 순지트를 포함하는 샴푸 조성물 | |
KR102190612B1 (ko) | 식물성 원료, 미생물 원료 또는 해양성 원료로부터 유래된 저분자량 dna의 제조방법 | |
JP2011213673A (ja) | 生理活性低分子化合物の生成方法 | |
CN116963614A (zh) | 经过三个步骤加工处理的发酵鹿茸提取物的制备方法 | |
KR20180088173A (ko) | 큰실말 추출물을 유효성분으로 포함하는 화장료 조성물 | |
KR20080049174A (ko) | 레몬 과피로부터 디오스메틴을 제조하는 방법 및 이를유효성분으로 함유하는 화장료 조성물 | |
KR102225585B1 (ko) | 증삼액 가공물을 포함하는 피부 주름 개선용 화장료 조성물 | |
KR20190029198A (ko) | 미백 기능 및 항주름 기능이 우수한 기능성 화장품용 후코이단 발효산물의 제조방법 | |
CN115368334B (zh) | 一种提高竹叶总黄酮浸取效率的方法 | |
Yunhai et al. | In vitro antibacterial activity of fucoidan islolated from Ascophyllum nodosum and Laminaria digitata |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
AMND | Amendment | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130304 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140228 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150227 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160302 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170224 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180302 Year of fee payment: 12 |
|
LAPS | Lapse due to unpaid annual fee |